A major quantitative factor that really favors Ralph Laruen is its ROE topping +36%, being the 2nd highest in this peer group ...

Becton, Dickinson and Company gets its prior buy rating reaffirmed again, agreeing with the latest Wall St. consensus. Key strengths are its diverse and growing clinical portfolio expected to drive ...

We may earn commission from links on this page, but we only recommend products we love. Promise. “Don’t worry. Women like you don’t get left on the shelf.” I couldn’t quite believe my eyes when these ...

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.